Cargando…

DYRK1A phosphorylates MEF2D and decreases its transcriptional activity

Myocyte enhancer factor 2D (MEF2D) is predominantly expressed in the nucleus and associated with cell growth, differentiation, survival and apoptosis. Previous studies verified that phosphorylation at different amino acids determined MEF2's transcriptional activity which was essential in regula...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Pin, Zhao, Juan, Sun, Xiulian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256340/
https://www.ncbi.nlm.nih.gov/pubmed/34109727
http://dx.doi.org/10.1111/jcmm.16505
_version_ 1783718081967685632
author Wang, Pin
Zhao, Juan
Sun, Xiulian
author_facet Wang, Pin
Zhao, Juan
Sun, Xiulian
author_sort Wang, Pin
collection PubMed
description Myocyte enhancer factor 2D (MEF2D) is predominantly expressed in the nucleus and associated with cell growth, differentiation, survival and apoptosis. Previous studies verified that phosphorylation at different amino acids determined MEF2's transcriptional activity which was essential in regulating downstream target genes expression. What regulates phosphorylation of MEF2D and affects its function has not been fully elucidated. Here, we uncovered that dual‐specificity tyrosine phosphorylation regulated kinase 1A (DYRK1A), a kinase critical in Down's syndrome pathogenesis, directly bound to and phosphorylated MEF2D at Ser251 in vitro. Phosphorylation of MEF2D by DYRK1A significantly increased MEF2D protein level but attenuated its transcriptional activity, which resulted in decreased transcriptions of MEF2D target genes. Phosphorylation mutated Ser251A MEF2D exhibited enhanced transcriptional activity compared with wild type MEF2D. MEF2D and DYRK1A were observed co‐localized in HEK293 and U87MG cells. Moreover, DYRK1A‐mediated MEF2D phosphorylation in vitro might influence its nuclear export upon subcellular fractionation, which partially explained the reduction of MEF2D transcriptional activity by DYRK1A. Our results indicated that DYRK1A might be a regulator of MEF2D transcriptional activity and indirectly get involved in regulation of MEF2D target genes.
format Online
Article
Text
id pubmed-8256340
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82563402021-07-12 DYRK1A phosphorylates MEF2D and decreases its transcriptional activity Wang, Pin Zhao, Juan Sun, Xiulian J Cell Mol Med Original Articles Myocyte enhancer factor 2D (MEF2D) is predominantly expressed in the nucleus and associated with cell growth, differentiation, survival and apoptosis. Previous studies verified that phosphorylation at different amino acids determined MEF2's transcriptional activity which was essential in regulating downstream target genes expression. What regulates phosphorylation of MEF2D and affects its function has not been fully elucidated. Here, we uncovered that dual‐specificity tyrosine phosphorylation regulated kinase 1A (DYRK1A), a kinase critical in Down's syndrome pathogenesis, directly bound to and phosphorylated MEF2D at Ser251 in vitro. Phosphorylation of MEF2D by DYRK1A significantly increased MEF2D protein level but attenuated its transcriptional activity, which resulted in decreased transcriptions of MEF2D target genes. Phosphorylation mutated Ser251A MEF2D exhibited enhanced transcriptional activity compared with wild type MEF2D. MEF2D and DYRK1A were observed co‐localized in HEK293 and U87MG cells. Moreover, DYRK1A‐mediated MEF2D phosphorylation in vitro might influence its nuclear export upon subcellular fractionation, which partially explained the reduction of MEF2D transcriptional activity by DYRK1A. Our results indicated that DYRK1A might be a regulator of MEF2D transcriptional activity and indirectly get involved in regulation of MEF2D target genes. John Wiley and Sons Inc. 2021-06-09 2021-07 /pmc/articles/PMC8256340/ /pubmed/34109727 http://dx.doi.org/10.1111/jcmm.16505 Text en © 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Wang, Pin
Zhao, Juan
Sun, Xiulian
DYRK1A phosphorylates MEF2D and decreases its transcriptional activity
title DYRK1A phosphorylates MEF2D and decreases its transcriptional activity
title_full DYRK1A phosphorylates MEF2D and decreases its transcriptional activity
title_fullStr DYRK1A phosphorylates MEF2D and decreases its transcriptional activity
title_full_unstemmed DYRK1A phosphorylates MEF2D and decreases its transcriptional activity
title_short DYRK1A phosphorylates MEF2D and decreases its transcriptional activity
title_sort dyrk1a phosphorylates mef2d and decreases its transcriptional activity
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256340/
https://www.ncbi.nlm.nih.gov/pubmed/34109727
http://dx.doi.org/10.1111/jcmm.16505
work_keys_str_mv AT wangpin dyrk1aphosphorylatesmef2danddecreasesitstranscriptionalactivity
AT zhaojuan dyrk1aphosphorylatesmef2danddecreasesitstranscriptionalactivity
AT sunxiulian dyrk1aphosphorylatesmef2danddecreasesitstranscriptionalactivity